The Florida government announced Wednesday that it has issued a subpoena to Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases (NIAID), as part of an investigation to determine whether he profited financially from his role during the COVID-19 pandemic.
Attorney General James Uthmeier stated that the subpoena aims to obtain documentation regarding decisions Fauci made during the health emergency, as well as information on potential income from publishing contracts, awards, and other activities that, according to state authorities, could have generated personal gain.
In an interview with Fox News, Uthmeier explained that the investigation also seeks to clarify what the scientist knew about the safety and efficacy of vaccines promoted during the pandemic and when he had access to that information.
The Republican official maintained that there are indications that Fauci attempted to profit through publishing deals, public endorsements, and connections with high-net-worth individuals, which, in his opinion, could constitute a violation of Florida law.
According to the prosecutor, the potential irregularities could fall under categories such as deceptive business practices, fraud, or actions contrary to the public interest, although he specified that the investigation is ongoing.
The decision comes just days after Fauci’s appearance before the U.S. Senate, where he was questioned by lawmakers, including Republican Senator Rand Paul, about his role during the health crisis.
During that hearing, the former official invoked his Fifth Amendment right to remain silent 111 times, which protects a person’s right to remain silent when they believe their answers could incriminate them.
In addition to the investigation initiated in Florida, Fauci will also face inquiries initiated by authorities in Alabama and Louisiana. Senator Rand Paul announced he will pursue contempt of court charges against the former official for refusing to answer questions during the congressional hearing.
Fauci was a leading figure in the U.S. public health response to the pandemic and advised both the Trump and Biden administrations during the coronavirus emergency.
